3d漫画全彩我的熟妇老师,欧美精品大香伊蕉在人线,男人激烈吮乳吃奶视频免费

規(guī)格	庫(kù)存	目錄價(jià)	會(huì)員專(zhuān)享價(jià)	數(shù)量
10 mg	In-stock	￥426.00	登錄后可見(jiàn)	- +
50 mg	In-stock	￥1266.00	登錄后可見(jiàn)	- +
100 mg	In-stock	￥1986.00	登錄后可見(jiàn)	- +

規(guī)格

庫(kù)存

目錄價(jià)

會(huì)員專(zhuān)享價(jià)

數(shù)量

10 mg

In-stock

￥426.00

登錄后可見(jiàn)

- +

50 mg

In-stock

￥1266.00

登錄后可見(jiàn)

- +

100 mg

In-stock

￥1986.00

登錄后可見(jiàn)

- +

基本信息

英文名稱(chēng)	Mirdametinib (PD0325901)
中文名稱(chēng)	N-[(2R)-2,3-二羥基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺
CAS號(hào)	391210-10-9
分子式	C16H14F3IN2O4
分子量	482.19
外觀(guān)	White powder
儲(chǔ)存條件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

產(chǎn)品詳情

Mirdametinib, also known as PD-0325901, is a potent bioavailable and selective MEK inhibitor, which targets mitogen-activated protein kinase kinase (MAPK/ERK kinase or MEK) with potential antineoplastic activity. MEK inhibitor PD325901, a derivative of MEK inhibitor CI-1040, selectively binds to and inhibits MEK, which may result in the inhibition of the phosphorylation and activation of MAPK/ERK and the inhibition of tumor cell proliferation. The dual specific threonine/tyrosine kinase MEK is a key component of the RAS/RAF/MEK/ERK signaling pathway that is frequently activated in human tumors.

相關(guān)文獻(xiàn)

抱歉，暫時(shí)沒(méi)有相關(guān)文獻(xiàn)

相關(guān)產(chǎn)品

抱歉，暫時(shí)沒(méi)有相關(guān)產(chǎn)品

瀏覽記錄

CL1077

N-[(2R)-2,3-二羥基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺

391210-10-9 99+% In-stock

￥426.00 10 mg

51精产国品一二三产区区别,极品尤物一区二区三区小说,亚洲乱码爆乳精品成人毛片,99久久综合狠狠综合久久

N-[(2R)-2,3-二羥基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺

Mirdametinib (PD0325901)

化學(xué)品安全說(shuō)明書(shū)(MSDS)

質(zhì)檢證書(shū)(COA)